Home/Filings/4/0001628908-23-000178
4//SEC Filing

McCarthy Daniel Joseph 4

Accession 0001628908-23-000178

CIK 0001628908other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 8:01 AM ET

Size

11.4 KB

Accession

0001628908-23-000178

Insider Transaction Report

Form 4
Period: 2023-11-15
Transactions
  • Sale

    Class A Common Stock

    2023-11-15$30.00/sh4,000$120,000202,333 total
  • Sale

    Class A Common Stock

    2023-11-15$30.00/sh4,000$120,000198,333 total
  • Sale

    Class A Common Stock

    2023-11-15$30.00/sh3,000$90,000198,333 total
  • Exercise/Conversion

    Class A Common Stock

    2023-11-15$10.65/sh+3,000$31,950201,333 total
  • Exercise/Conversion

    Class A Common Option (right to buy)

    2023-11-153,0000 total
    Exercise: $10.65Exp: 2025-05-12Class A Common Stock (3,000 underlying)
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2023.
  • [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F3]The Class A Common Stock Options exercised vested on May 12, 2019.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001946147

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 8:01 AM ET
Size
11.4 KB